# Advisor Review - GPT-5.2

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Timestamp:** 2026-01-30T22:58:08.817817
**Response ID:** resp_0246e969c2542dfd00697d288ad79c8193ae616cf1621823b1
**Tokens:** 27103 in / 8060 out
**Response SHA256:** 33884569d7da94a4

---

## 1) DATA–DESIGN ALIGNMENT (CRITICAL)

### a) Treatment timing vs. data coverage
- **Data window:** 2005–2023, excluding 2020 → **18 years**, consistent with **51 × 18 = 918** state-year observations (as stated in Section 4.2 and Table 2 notes).
- **Treatment timing:** RPS adoption/compliance years are **≤ 2015** (Table 5; also stated throughout).
- **Alignment check:** **max(treatment year) = 2015 ≤ max(data year) = 2023** → **OK (no fatal mismatch).**

### b) Post-treatment observations
- Latest cohort is **2015**, with post years **2015–2019 and 2021–2023** → **8 post-treatment years** available → **OK.**
- Early treated states (≤ 2005) are explicitly handled: they are **already-treated at panel start** and are **not identified** under CS-DiD (stated consistently in Sections 2.2, 4.2, 5.2.1, Table 2 notes) → **OK.**

### c) Treatment definition consistency
- Treatment is consistently defined as “**first year of binding compliance**” (e.g., Sections 2.2, 4.3, Table 2 notes, Table 5 “First Year”).
- The “identified treated states” count is internally consistent: **35 ever-treated − 10 treated-by-2005 = 25 identifiable treated** (Table 2; Sections 2.2 and 4.2) → **OK.**

**No fatal data–design alignment errors found.**

---

## 2) REGRESSION SANITY (CRITICAL)

I checked the reported tables for broken outputs.

- **Table 2 (main DiD estimates):** coefficients and SEs are in plausible ranges; no extreme SE/coefficient ratios; CIs look coherent.
- **Table 3 (event study):** coefficients/SEs are plausible for an outcome measured in jobs per 1,000; no impossible values.
- **Table 4 (robustness / placebo):** magnitudes and SEs are plausible; no “Inf/NaN/NA”; nothing suggests collinearity-induced blowups.
- **Table 6 (estimator comparison):** all entries numerically coherent; CIs match coefficient ± ~1.96·SE.
- **Tables 7–8:** diagnostics summaries are numerically consistent (no impossible values).

**No fatal regression sanity errors found.**

---

## 3) COMPLETENESS (CRITICAL)

- No placeholders (“TBD”, “TODO”, “XXX”, “NA/NaN/Inf”) appear in the reported results tables.
- Regression tables report inference (SEs and/or CIs) and sample size context:
  - Table 2 reports **Observations = 918** and clusters.
  - Event-study table includes inference and notes **N = 918**.
  - Robustness tables report N and/or are clearly tied to the same panel.
- Figures and tables referenced in the provided draft (Figures 1–6, Tables 1–8) appear to exist in-text and/or in the appendix material you provided.

**No fatal completeness errors found.**

---

## 4) INTERNAL CONSISTENCY (CRITICAL)

Key cross-checks:
- The headline CS-DiD estimate in the abstract (**+0.112, SE 0.097, p 0.251**) matches Table 2 Column (2) (**0.1117, 0.0974**).
- The stated CI (**[−0.079, +0.303]**) matches Table 2’s CI.
- Mean outcome used for % interpretation (**2.353 per 1,000**) matches Table 1.
- Counts of treated/never-treated and “identified cohorts” are consistent across Section 4.2, Table 2, and Table 5.
- Sample years and omission of 2020 are consistently stated across data, tables, and figure notes.

**No fatal internal consistency errors found.**

---

ADVISOR VERDICT: PASS